Martin Shkreli, former head of Turing Pharmaceuticals refused to answer questions at a US congressional hearing on the company's drug pricing policy.
Martin Shkreli, former head of Turing Pharmaceuticals, refused to answer questions at a US congressional hearing on the company's drug pricing policy.